Literature DB >> 8261420

Statistical analysis of in vivo tumor growth experiments.

D F Heitjan1, A Manni, R J Santen.   

Abstract

We review and compare statistical methods for the analysis of in vivo tumor growth experiments. The methods most commonly used are deficient in that they have either low power or misleading type I error rates. We propose a set of multivariate statistical modeling methods that correct these problems, illustrating their application with data from a study of the effect of alpha-difluoromethylornithine on growth of the BT-20 human breast tumor in nude mice. All the methods find significant differences between the alpha-difluoromethylornithine dose groups, but recommended sample sizes for a subsequent study are much smaller with the multivariate methods. We conclude that the multivariate methods are preferable and present guidelines for their use.

Entities:  

Mesh:

Year:  1993        PMID: 8261420

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  29 in total

1.  A model-based approach for assessing in vivo combination therapy interactions.

Authors:  A M Lopez; M D Pegram; D J Slamon; E M Landaw
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Statistical inference for tumor growth inhibition T/C ratio.

Authors:  Jianrong Wu
Journal:  J Biopharm Stat       Date:  2010-09       Impact factor: 1.051

3.  Intracellular delivery system for antibody-Peptide drug conjugates.

Authors:  Geoffrey Y Berguig; Anthony J Convertine; Shani Frayo; Hanna B Kern; Erik Procko; Debashish Roy; Selvi Srinivasan; Daciana H Margineantu; Garrett Booth; Maria Corinna Palanca-Wessels; David Baker; David Hockenbery; Oliver W Press; Patrick S Stayton
Journal:  Mol Ther       Date:  2015-02-11       Impact factor: 11.454

Review 4.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 5.  Three endpoints of in vivo tumour radiobiology and their statistical estimation.

Authors:  Eugene Demidenko
Journal:  Int J Radiat Biol       Date:  2010-02       Impact factor: 2.694

6.  Biology, models, and the analysis of tumor xenograft experiments.

Authors:  Daniel F Heitjan
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

7.  Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.

Authors:  Jianqiang Wu; Eva Dombi; Edwin Jousma; R Scott Dunn; Diana Lindquist; Beverly M Schnell; Mi-Ok Kim; Aerang Kim; Brigitte C Widemann; Timothy P Cripe; Nancy Ratner
Journal:  Pediatr Blood Cancer       Date:  2011-02-11       Impact factor: 3.167

8.  Reporting of preclinical tumor-graft cancer therapeutic studies.

Authors:  Elizabeth Sugar; Adam J Pascoe; Nilofer Azad
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

9.  The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis.

Authors:  Luisana Astudillo; Thiago G Da Silva; Zhiqiang Wang; Xiaoqing Han; Ke Jin; Jeffrey VanWye; Xiaoxia Zhu; Kelly Weaver; Taiji Oashi; Pedro E M Lopes; Darren Orton; Leif R Neitzel; Ethan Lee; Ralf Landgraf; David J Robbins; Alexander D MacKerell; Anthony J Capobianco
Journal:  Cancer Res       Date:  2016-04-13       Impact factor: 12.701

10.  Effects of the conjugated equine estrogen/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice.

Authors:  Yan Song; Richard J Santen; Ji-ping Wang; Wei Yue
Journal:  Endocrinology       Date:  2012-10-15       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.